We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Mitsubishi UFJ Trust & Banking
251
Mitsubishi UFJ Trust & Banking
Japan
$406K +$367K +7,450 New
MAM
252
Meeder Asset Management
Ohio
$401K +$362K +7,353 New
ARMC
253
American Research & Management Company
Massachusetts
$397K +$359K +7,291 New
SB
254
Suntrust Banks
Georgia
$391K +$354K +7,190 New
CPA
255
Court Place Advisors
Maryland
$387K +$350K +7,103 New
SCM
256
Shelton Capital Management
Colorado
$387K +$350K +7,115 New
HCM
257
Hodges Capital Management
Texas
$382K +$345K +7,006 New
BCM
258
Bourgeon Capital Management
Connecticut
$376K +$340K +6,906 New
ARTA
259
A.R.T. Advisors
New York
$359K +$325K +6,600 New
HIIFS
260
Harel Insurance Investments & Financial Services
Israel
$347K +$304K +6,174 New
EP
261
Elkfork Partners
Oregon
$344K +$312K +6,324 New
MCM
262
Matarin Capital Management
New York
$341K +$309K +6,269 New
Skandinaviska Enskilda Banken (SEB)
263
Skandinaviska Enskilda Banken (SEB)
Sweden
$341K +$308K +6,257 New
TAM
264
Trillium Asset Management
Massachusetts
$340K +$308K +6,244 New
OAC
265
OMERS Administration Corp
Ontario, Canada
$321K +$291K +5,900 New
QF
266
QVT Financial
New York
$320K +$290K +5,879 New
CCP
267
Cardan Capital Partners
Colorado
$318K +$288K +5,848 New
AMI
268
Amica Mutual Insurance
Rhode Island
$309K +$279K +5,667 New
IHL
269
Investment House LLC
California
$309K +$280K +5,679 New
KAM
270
Kazazian Asset Management
Florida
$305K +$276K +5,598 New
OPPM
271
Opus Point Partners Management
New York
$304K +$275K +5,587 New
MME
272
Meag Munich Ergo
Germany
$297K +$278K +5,644 New
William Blair & Company
273
William Blair & Company
Illinois
$294K +$276K +5,599 New
Schroder Investment Management Group
274
Schroder Investment Management Group
United Kingdom
$291K +$263K +5,347 New
OI
275
Oakbrook Investments
Illinois
$291K +$263K +5,348 New
9 10
11
12 13

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.